Clinical Trial

Efficacy and Safety of Surgical Treatment for Type IVa CBD

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a multicenter, bidirectional cohort study aimed at continuously enrolling patients with biliary dilatation from 25 medical centers in China. It will collect comprehensive life-cycle data from the cohort to establish a Chinese cohort for IVa biliary dilatation (BD). Based on this cohort, the study seeks to compare the perioperative risks, long-term outcomes, and quality of life of type IVa BD following surgical treatment, to establish standardized surgical treatment strategies for type IVa BD.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-17.
Status change: Not Yet Recruiting → Recruiting 2025-07-14
Trial Details
NCT Number NCT07036848
Lead Sponsor Beijing Tsinghua Chang Gung Hospital
Conditions Choledochal Cyst
Enrollment 1,500 participants
Start Date 2025-07-14
Primary Completion 2025-07-14 (estimated)
Study Completion 2035-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-17